Control of motor seizures by brotizolam with maintenance of stable refractory periods for self-stimulation.
In recent years, we have been pursuing our mapping investigations of the substrate for brain-stimulation reward in regions of the anterior hypothalamic and lateral preoptic areas. However, one problem is that stimulation of these sites often generates overt seizures so that their suppression via a pharmacological means would be very useful. The sedative-hypnotic benzodiazepine, brotizolam, is reportedly a long-lasting anticonvulsant. Hence, its effects on motor seizures elicited from stimulation of the lateral preoptic area were evaluated in the first experiment. Both tested doses (5.0 and 7.5 mg/kg) of the drug were shown to significantly decrease the number, and marginally, the severity of stimulation-induced seizures; furthermore, this effect was relatively long lasting, up to about 3 h. The higher dose of brotizolam did not alter the single-pulse thresholds for self-stimulation, a requirement for evaluations of poststimulation excitability, the purpose of the second experiment. Here, our interest was in documenting whether the membrane properties of the stimulated neurons, as assessed by refractory periods, were altered by brotizolam. No differences in the time course of recovery were observed; refractoriness began between 0.4 and 0.8 ms, and reached 50% recovery by 2.0 ms, which is consistent with the pattern of poststimulation excitability typically measured at these sites. Thus, in addition to its long-lasting suppression of motor seizures in rats, brotizolam does not alter the time course of recovery from refractoriness of the neurons that mediate brain-stimulation reward in the lateral preoptic area.
Bielajew
C
C
School of Psychology, University of Ottawa, Ontario, Canada. CATCH@UOTTAWA.CA
Bushnik
T
T
Konkle
A T
AT
Parkin
E
E
D000704:Analysis of Variance; D000818:Animals; D001381:Azepines / Q000494:pharmacology*; D001931:Brain Mapping / Q000379:methods*; D004558:Electric Stimulation / Q000009:adverse effects; D006993:Hypnotics and Sedatives / Q000494:pharmacology*; D007026:Hypothalamic Area, Lateral / Q000187:drug effects / Q000502:physiology; D008297:Male; D011301:Preoptic Area / Q000187:drug effects / Q000502:physiology; D051381:Rats; D020318:Rats, Long-Evans; D012033:Refractory Period, Psychological / Q000187:drug effects; D012201:Reward; D012640:Seizures / Q000209:etiology / Q000517:prevention & control*; D012653:Self Stimulation / Q000187:drug effects / Q000502:physiology*; D012684:Sensory Thresholds / Q000187:drug effects
D001381:Azepines; D006993:Hypnotics and Sedatives; C020960:brotizolam